secwatch.observer — SEC 8-K summary
======================================

Issuer:     Picard Medical, Inc. (PMI)
CIK:        0002030617
Form:       8-K
Filed at:   2025-11-19T23:59:59+00:00
Accession:  0001829126-25-009304
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SynCardia implants Emperor Total Artificial Heart in first in vivo study
------------------------------------------------------------------------

- Three pre-clinical models successfully implanted with the Emperor TAH; all taken off bypass without issues.
- Device provided full, stable blood circulation with efficient energy use and no technical problems.
- Emperor TAH exhibited Frank-Starling response: natural pump output adjustment based on blood volume.
- Results consistent with Picard Medical's laboratory performance goals; program acceleration expected.
- Emperor platform designed as a fully implantable successor to the FDA-approved SynCardia TAH.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030617/000182912625009304/0001829126-25-009304-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030617/000182912625009304/picardmedical_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-009304

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer